healthNewsغير مصنف

Express Scripts drops coverage of Valeant diabetes drug Glumetza

NEW YORK (Reuters) – Express Scripts Holding Co, the U.S. No. 1 pharmacy benefits manager, said on Friday it would stop covering Glumetza, a diabetes drug made by Valeant Pharmaceuticals International Inc, after a generic competitor enters the market on Feb. 1.


اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى